Merck & Schering-Plough Disclose More Details On Their Merger
This article was originally published in The Pink Sheet Daily
Executive Summary
To resolve shareholder suits, info is disclosed about arbitration over Remicade and Simponi, and "deal protection" provisions, among other things.